Bladder Cancer

>

Latest News

Avelumab Maintenance Therapy Enhances Survival in Advanced Urothelial Cancer
Avelumab Maintenance Therapy Enhances Survival in Advanced Urothelial Cancer

February 18th 2025

Avelumab plus best supportive care improved survival vs best supportive care alone in advanced urothelial carcinoma, regardless of diabetes status.

Enfortumab Vedotin Improves Outcomes in Advanced Urothelial Cancer
Enfortumab Vedotin Improves Outcomes in Advanced Urothelial Cancer

February 17th 2025

Enfortumab Vedotin Combo Doubles PFS vs Chemo in Urothelial Cancer
Enfortumab Vedotin Combo Doubles PFS vs Chemo in Urothelial Cancer

February 15th 2025

Datopotamab Deruxtecan Shows Promise in Advanced Urothelial Cancer
Datopotamab Deruxtecan Shows Promise in Advanced Urothelial Cancer

February 15th 2025

UGN-102 Shows Lasting Responses in Low-Grade, Intermediate-Risk NMIBC
UGN-102 Shows Lasting Responses in Low-Grade, Intermediate-Risk NMIBC

February 15th 2025

Video Series
Video Interviews

More News